Estee Lauder stock plunges, withdraws full-year outlook on China uncertainty
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Estee Lauder (EL) PT Lowered to $70 at B.Riley
November 4, 2024 5:16 AM ESTB.Riley analyst Anna Glaessgen lowered the price target on Estee Lauder (NYSE: EL) to $70.00 (from $95.00) while maintaining a Neutral rating.
The analyst comments "Worsening Chinese consumer sentiment drives meaningful reduction to FY25 estimates. The prestige beauty industry in... More
Evercore ISI Reiterates Outperform Rating on Estee Lauder (EL)
October 31, 2024 8:55 AM EDTEvercore ISI analyst Robert Ottenstein reiterated an Outperform rating and $130.00 price target on Estee Lauder (NYSE: EL).
The analyst comments "Estees reliance on China, mainland and throughout travel corridors, is underscored yet again. There are no multiple engines of growth, at least not profitable ones, and as Asia Travel Retail stopped taking orders, operating losses elsewhere surface. Results suggest significant organizational and commercial weaknesses and challenges outside Asia. For... More
Citi Downgrades Estee Lauder (EL) to Neutral
October 31, 2024 8:53 AM EDTCiti analyst Filippo Falorni downgraded Estee Lauder (NYSE: EL) from Buy to Neutral with a price target of $80.00 (from $105.00).
The analyst comments "Even though the bar was very low for EL, F1Q25 results and guidance update were much worse than... More

